C WorldWide Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9M Buy
280,000
+100,000
+56% +$5.43M 0.29% 49
2026
Q1
$11.3M Buy
+180,000
New +$14.4M 0.24% 49
2019
Q2
Sell
-367,194
Closed -$14.1M 91
2019
Q1
$14.1M Hold
367,194
0.18% 31
2018
Q4
$13M Hold
367,194
0.19% 31
2018
Q3
$14.1M Hold
367,194
0.18% 34
2018
Q2
$12M Hold
367,194
0.17% 36
2018
Q1
$10M Hold
367,194
0.15% 39
2017
Q4
$9.1M Hold
367,194
0.13% 48
2017
Q3
$10.7M Sell
367,194
-14,278
-4% -$394K 0.15% 42
2017
Q2
$10.6M Buy
+381,472
New +$10.1M 0.16% 49
2015
Q4
Sell
-150,000
Closed -$2.46M 134
2015
Q3
$2.46M Hold
150,000
0.04% 79
2015
Q2
$2.65M Buy
+150,000
New +$2.68M 0.04% 85

Other funds holding BSX

C WorldWide Group's BSX Position: Q2 2026 in Review

C WorldWide Group increased its Boston Scientific (BSX) stake by 56% in Q2 2026, buying an estimated $5.43M and bringing the position to 280,000 shares worth $11.9M. The position accounts for 0.29% of the portfolio, ranked #49.

C WorldWide Group first reported a position in BSX in Q2 2015 and has held it in 12 quarters since. The position peaked at $14.1M in Q3 2018. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • C WorldWide Group held 280,000 shares of Boston Scientific worth $11.9M as of Q2 2026.
  • C WorldWide Group bought 100,000 Boston Scientific shares in Q2 2026, an estimated $5.43M.
  • Boston Scientific made up 0.29% of C WorldWide Group's portfolio in Q2 2026, its #49 holding.
  • C WorldWide Group first reported a position in Boston Scientific in Q2 2015 and has held it in 12 quarters since.
  • C WorldWide Group's Boston Scientific position peaked at $14.1M in Q3 2018.
  • 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on C WorldWide Group's 13F filing for Q2 2026, filed 4 Aug 2026.